National Heart Institute: Daily Statin Reduces Heart Disease Risk Among Adults Living With HIV
July 25, 2023
July 25, 2023
BETHESDA, Maryland, July 25 -- The National Institutes of Health's National Heart, Lung and Blood Institute issued the following news release:
* * *
NIH-funded clinical trial finds cholesterol-lowering treatment reduced cardiovascular events by 35%
* * *
A National Institute of Health-supported study found that statins, a class of cholesterol-lowering medications, may offset the high risk of cardiovascular disease in people living with HIV . . .
* * *
NIH-funded clinical trial finds cholesterol-lowering treatment reduced cardiovascular events by 35%
* * *
A National Institute of Health-supported study found that statins, a class of cholesterol-lowering medications, may offset the high risk of cardiovascular disease in people living with HIV . . .